🔥 M&A News 🔥
$AbbVie(ABBV.US$ to acquire $Landos Biopharma(LABP.US$
⇒ $137.5M deal at $20.42/sh 💰💰
⇒ strengthens portfolio in inflammatory & autoimmune diseases
⇒ Adds lead asset NX-13 (Ph2 trial UC)
⇒ $137.5M deal at $20.42/sh 💰💰
⇒ strengthens portfolio in inflammatory & autoimmune diseases
⇒ Adds lead asset NX-13 (Ph2 trial UC)
$Nuvation Bio(NUVB.US$ to acquire AnHeart Therapeutics
⇒ all-stock transaction
⇒ transforms NUVB into late-stage global oncology company
⇒ Includes taletrectinib with ongoing trials NSCLC)
⇒ all-stock transaction
⇒ transforms NUVB into late-stage global oncology company
⇒ Includes taletrectinib with ongoing trials NSCLC)
$Novo-Nordisk A/S(NVO.US$ to acquire Cardior Pharmaceuticals
⇒ 1.025 B euros deal 💰💰
⇒ strengthens pipeline in CV disease
⇒ includes lead asset CDR132L (Ph2 trial heartfailure)
⇒ 1.025 B euros deal 💰💰
⇒ strengthens pipeline in CV disease
⇒ includes lead asset CDR132L (Ph2 trial heartfailure)
![🔥 M&A News 🔥](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240326/3f8cbdbc37a7497cac29b7e4a4cfd460.png/big?area=100&is_public=true)
![🔥 M&A News 🔥](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240326/ef98dc093f964e469be42a8e021616ac.png/big?area=100&is_public=true)
![🔥 M&A News 🔥](https://ussnsimg.moomoo.com/sns_client_feed/70042970/20240326/7f5ab3ff32af4866868d02c7d8a1c8fa.png/big?area=100&is_public=true)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment